Pluristyx - Crunchbase Company Profile & Funding

Q: Where is Pluristyx's headquarters?

Pluristyx is located in Seattle, Washington, United States.

Q: Who invested in Pluristyx?

Pluristyx has 2 investors including BroadOak Capital Partners And BioLife Solutions.

Q: When was the last funding round for Pluristyx?

Pluristyx closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Pluristyx

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Pluristyx

CB Rank

152104

Pluristyx is a leading chemistry, manufacturing, and controls (CMC), consulting, process development

Founded

obfuscation

Private

Venture - Series Unknown

Seattle, Washington, United States

11-50

www.pluristyx.com/

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Benjamin Fryer: Co-Founder and CEO
Past Role: University of Washington, Team Leader, CMC, Cardiomyocyte Cell Manufacturing

Details

Legal Name

Pluristyx, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Benjamin Fryer

About the Company

Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, expert consulting, and contract services.

Predictions & Insights

Growth Insight

See this Growth Insight

Pluristyx is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

PSXi013 iPSC Line

A GMP-compliant induced pluripotent stem cell line designed for clinical and research use, offering low passage number and genomic stability for cell therapy development.

FailSafe® Safety Switch

A genetic safety mechanism integrated into iPSC lines to selectively eliminate dividing cells upon drug activation, enhancing safety of cell therapies.

Research & Development

Pluristyx is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Pluristyx	2	obfuscated obfuscation	BioLife Solutions, BroadOak Capital Partners	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
BroadOak Capital Partners	Yes	Venture Round - Pluristyx	Daniel Friedman
BroadOak Capital Partners	Yes	Venture Round - Pluristyx	Daniel Friedman
BroadOak Capital Partners	Yes	Venture Round - Pluristyx	Daniel Friedman
BroadOak Capital Partners	Yes	Venture Round - Pluristyx	Daniel Friedman
BroadOak Capital Partners	Yes	Venture Round - Pluristyx	Daniel Friedman